AIM: The purpose of this study is to determine the central-axis dose in the buildup region and the surface dose delivered by a 6 MV flattened photon beam (6 MV-FB) and a higher energy unflattened (7 MV-FFF) therapeutic photon beam for different-sized square fields with open fields and modifying filters. MATERIALS AND METHODS: The beams are produced by a Siemens Artiste linear accelerator with a NACP-02 ionization chamber and the dose is measured by using GafChromic film and two different, commonly used, dosimeters: a p-type photon semiconductor dosimeter (PFD) and a cylindrical ionization chamber (CC13). RESULTS: The results indicate that the surface dose increases linearly with FS for both open and wedged fields for the 6 MV-FB and 7 MV-FFF beams. The surface dose delivered by the 7 MV-UFB beam is consistent with that delivered by the 6 MV-FB beam for field sizes up to 10 cm × 10 cm, after which the surface dose decreases. The buildup dose for the 7 MV-UFB beam is slightly less than that for the 6 MV-FB beam for field sizes ranging from 5 cm × 5 cm to 15 cm × 15 cm. For both the 6 MV-FB and 7 MV-FFF beams, the measured surface dose clearly increases with increasing field size, regardless of the detector used in the measurement. The surface dose measured with the PFD dosimeter and the NACP-02 and CC13 chambers differ significantly from the results obtained when using GafChromic film. The 7 MV-FFF beam results in a slightly smaller surface dose in the buildup region compared with the 6 MV-FB beam. CONCLUSIONS: The surface dose delivered by the higher energy 7 MV-FFF beam is less than that delivered by the energy-unmatched FFF beam in previously published works.
AIM: The purpose of this study is to determine the central-axis dose in the buildup region and the surface dose delivered by a 6 MV flattened photon beam (6 MV-FB) and a higher energy unflattened (7 MV-FFF) therapeutic photon beam for different-sized square fields with open fields and modifying filters. MATERIALS AND METHODS: The beams are produced by a Siemens Artiste linear accelerator with a NACP-02ionization chamber and the dose is measured by using GafChromic film and two different, commonly used, dosimeters: a p-type photon semiconductor dosimeter (PFD) and a cylindrical ionization chamber (CC13). RESULTS: The results indicate that the surface dose increases linearly with FS for both open and wedged fields for the 6 MV-FB and 7 MV-FFF beams. The surface dose delivered by the 7 MV-UFB beam is consistent with that delivered by the 6 MV-FB beam for field sizes up to 10 cm × 10 cm, after which the surface dose decreases. The buildup dose for the 7 MV-UFB beam is slightly less than that for the 6 MV-FB beam for field sizes ranging from 5 cm × 5 cm to 15 cm × 15 cm. For both the 6 MV-FB and 7 MV-FFF beams, the measured surface dose clearly increases with increasing field size, regardless of the detector used in the measurement. The surface dose measured with the PFD dosimeter and the NACP-02 and CC13 chambers differ significantly from the results obtained when using GafChromic film. The 7 MV-FFF beam results in a slightly smaller surface dose in the buildup region compared with the 6 MV-FB beam. CONCLUSIONS: The surface dose delivered by the higher energy 7 MV-FFF beam is less than that delivered by the energy-unmatched FFF beam in previously published works.
Authors: Joanna L Perkins; Yan Liu; Pauline A Mitby; Joseph P Neglia; Sue Hammond; Marilyn Stovall; Anna T Meadows; Ray Hutchinson; Zoann E Dreyer; Leslie L Robison; Ann C Mertens Journal: J Clin Oncol Date: 2005-06-01 Impact factor: 50.717